|
Market Closed -
Toronto S.E.
00:00:00 19/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 5.050 CAD | +0.40% |
|
-0.59% | +73.54% |
| 08-11 | Medexus Pharmaceuticals Inc., Q1 2027 Earnings Call, Aug 11, 2026 | |
| 08-11 | Medexus Pharmaceuticals Fiscal Q1 Net Income, Revenue Rise Year-on-Year | MT |
| Market Cap | 159M 113M 98.79M 93.28M 84.7M 10.87B 159M 1.12B 431M 5.53B 426M 416M 17.78B | P/E 2027 * |
22x | P/E 2028 * | 6.09x |
|---|---|---|---|---|---|
| Enterprise Value | 159M 113M 98.79M 93.28M 84.7M 10.87B 159M 1.12B 431M 5.53B 426M 416M 17.78B | EV / Sales 2027 * |
0.97x | EV / Sales 2028 * | 0.81x |
| Free-Float |
93.53% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| MDP | Delayed | |
OTC Markets
| MEDXF | Delayed | |
|
Deutsche Boerse AG
| P731 | Delayed |
Last Transcript: Medexus Pharmaceuticals Inc.
| 1 day | +0.40% | ||
| 1 week | -0.59% | ||
| Current month | -3.63% | ||
| 1 month | -0.39% | ||
| 3 months | +20.24% | ||
| 6 months | +60.83% | ||
| Current year | +73.54% |
| 1 week | 4.85 |  | 5.09 |
| 1 month | 4.6 | | 5.3 |
| Current year | 2.65 | | 5.5 |
| 1 year | 2.51 | | 5.5 |
| 3 years | 1.44 | | 5.56 |
| 5 years | 0.88 | | 5.56 |
| 10 years | 0.88 | | 9.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 17/12/2018 | |
Brendon Buschman
DFI | Director of Finance/CFO | - | 01/06/2019 |
| General Counsel | - | 08/11/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Mueller
CHM | Chairman | 66 | 11/04/2023 |
Benoit Gravel
BRD | Director/Board Member | - | 22/09/2017 |
| Director/Board Member | - | 16/10/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 21/08/26 | Tax | Company | -1,000 | 0.0032% | - | |
| 21/08/26 | Tax | Company | 1,000 | 0.0032% | - | |
| 20/08/26 | Tax | Company | -8,100 | 0.0258% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.40% | -0.59% | +66.67% | +65.57% | 113M | |
| +0.04% | +3.34% | +53.32% | +100.52% | 1,028B | |
| -0.09% | +1.66% | +53.24% | +66.45% | 651B | |
| -0.02% | +2.66% | +18.65% | +71.97% | 466B | |
| -1.22% | +3.66% | +34.59% | +38.81% | 346B | |
| -0.79% | +2.73% | +17.73% | +25.11% | 266B | |
| +0.58% | +6.76% | +10.58% | +17.75% | 259B | |
| +1.55% | +2.20% | +35.12% | +45.91% | 208B | |
| +0.79% | +1.84% | -27.55% | -56.48% | 191B | |
| -0.52% | +4.45% | +31.57% | +98.11% | 186B | |
| Average | +0.07% | +2.87% | +29.39% | +47.37% | 360.18B | |
| Weighted average by Cap. | -0.04% | +3.09% | +34.85% | +61.60% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 163M 116M 102M 95.9M 87.09M 11.18B 164M 1.15B 443M 5.68B 438M 428M 18.28B | 197M 140M 122M 116M 105M 13.46B 197M 1.38B 534M 6.84B 527M 515M 22.02B |
| Net income | 7.47M 5.33M 4.65M 4.39M 3.99M 512M 7.5M 52.58M 20.29M 260M 20.03M 19.58M 837M | 26.89M 19.2M 16.74M 15.81M 14.35M 1.84B 27M 189M 73.07M 937M 72.11M 70.51M 3.01B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/09/26 | CA$5.050 | +0.40% | 28,920 |
| 17/09/26 | CA$5.030 | +0.60% | 21,170 |
| 16/09/26 | CA$5.000 | +1.42% | 21,811 |
| 15/09/26 | CA$4.930 | -1.60% | 63,642 |
| 14/09/26 | CA$5.010 | -1.38% | 28,996 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MDP Stock
Select your edition
All financial news and data tailored to specific country editions
